US2010166885A1PendingUtilityA1

Resuscitation Fluid

44
Assignee: UNIV SOUTH CAROLINAPriority: May 29, 2007Filed: Mar 12, 2010Published: Jul 1, 2010
Est. expiryMay 29, 2027(~0.9 yrs left)· nominal 20-yr term from priority
A61K 33/14A61P 7/04A61P 7/08A61K 38/38A61K 38/385A61K 31/221A61K 45/06
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a resuscitation fluid which includes an ionic salt at a concentration above about 0.9%, at least one soluble protein, at least one intermediate energy substrate, and optionally an agent to mitigate intracellular acidosis. Methods of making and using the fluid are also described.

Claims

exact text as granted — not AI-modified
1 - 41 . (canceled) 
   
   
       42 . A resuscitation fluid for treating hypovolemia in a subject, wherein the resuscitation fluid is a solution comprising:
 an ionic salt at a salt concentration between about 0.9% and about 15% by weight of the resuscitation fluid;   a soluble protein at a protein concentration between about 15% and about 40% by weight of the resuscitation fluid;   an intermediate energy substrate at an energy substrate concentration between about 0.1% and about 10% by weight of the resuscitation fluid; and   water.   
   
   
       43 . The resuscitation fluid according to  claim 42  further comprising a buffer. 
   
   
       44 . The resuscitation fluid according to  claim 43 , wherein the resuscitation fluid has a pH adjusted by the buffer to be between about 6.5 and about 7.0. 
   
   
       45 . The resuscitation fluid according to  claim 42 , wherein the ionic salt has a salt concentration between about 5% and about 10% by weight of the resuscitation fluid. 
   
   
       46 . The resuscitation fluid according to  claim 42 , wherein the protein concentration is between about 20% and about 30% by weight of the resuscitation fluid. 
   
   
       47 . The resuscitation fluid according to  claim 42 , wherein the energy substrate concentration is between about 0.5% and about 2% by weight of the resuscitation fluid. 
   
   
       48 . The resuscitation fluid according to  claim 42  further comprising an agent to mitigate intracellular acidosis. 
   
   
       49 . The resuscitation fluid according to  claim 48 , wherein the agent to mitigate intracellular acidosis is present in the resuscitation fluid at an agent concentration between about 0.2% and about 20% by weight of the resuscitation fluid. 
   
   
       50 . The resuscitation fluid according to  claim 48 , wherein the agent concentration is between about 0.5% and about 4% by weight of the resuscitation fluid. 
   
   
       51 . The resuscitation fluid according to  claim 48 , wherein the agent to mitigate intracellular acidosis is N-acetylcysteine. 
   
   
       52 . The resuscitation fluid according to  claim 42 , wherein the soluble protein comprises albumin. 
   
   
       53 . The resuscitation fluid according to  claim 52 , wherein the soluble protein comprises human serum albumin. 
   
   
       54 . The resuscitation fluid according to  claim 42 , wherein the intermediate energy substrate comprises a keto-acid containing a ketone functional group and a carboxylic acid group. 
   
   
       55 . The resuscitation fluid according to  claim 42 , wherein the intermediate energy substrate comprises a carboxylate anion of a keto-acid containing a ketone functional group and a carboxylic acid group. 
   
   
       56 . The resuscitation fluid according to  claim 42 , wherein the intermediate energy substrate comprises pyruvate. 
   
   
       57 . The resuscitation fluid according to  claim 42 , wherein the ionic salt comprises sodium chloride. 
   
   
       58 . A resuscitation fluid for treating hypovolemia in a subject, wherein the resuscitation fluid is a solution comprising;
 an ionic salt;   a soluble protein, wherein the soluble protein comprises albumin;   an intermediate energy substrate, wherein the intermediate energy substrate comprises pyruvate;   an agent to mitigate intracellular acidosis, wherein the agent to mitigate intracellular acidosis comprises N-acetylcysteine; and   water   
   
   
       59 . The resuscitation fluid according to  claim 58  further comprising a buffer, wherein the resuscitation fluid has a pH adjusted by the buffer to be between about 6.5 and about 7.0. 
   
   
       60 . The resuscitation fluid according to  claim 58 , wherein the resuscitation fluid comprises the ionic salt between about 0.9% and about 15% by weight; albumin between about 15% and about 40% by weight; pyruvate between about 0.1% and about 10% by weight; and N-acetylcysteine between about 0.2% and about 20% by weight.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.